Brief: India's Balaxi Pharmaceuticals June-Qtr Consol Net Profit Rises
Aug 2 (Reuters) - Balaxi Pharmaceuticals Ltd BALX.NS :
* JUNE-QUARTER CONSOL NET PROFIT 141.5 MILLION RUPEES VERSUS
PROFIT 107.1 MILLION RUPEES YEAR AGO
* JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 827.8 MILLION
RUPEES
VERSUS 583.4 MILLION RUPEES YEAR AGO
Further company coverage: BALX.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Balaxi Pharmaceuticals
See all newsBrief: Balaxi Pharmaceuticals Received WHO-GMP Certification For Jadcherla Facility
India's Balaxi Pharma up after Africa, Latam expansion
Brief: Balaxi Pharmaceuticals Expands Global Reach With Hospital Partnerships In Angola
Brief: Balaxi Pharmaceuticals To Set Up Pharmaceutical Formulation Plant In A Phased Manner
Brief: Balaxi Pharmaceuticals Approves Set Up Of First Pharmaceutical Formulation Plant At Jadcherla, Hyderabad